Campylobacter jejuni (Jones et al.) Veron and Chatelain (ATCC® BAA-2151)

Strain Designations: 81-176  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations 81-176
Application
Emerging infectious disease research
Enteric Research
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Campylobacter jejuni subsp. jejuni 81-176, complete genome

Type Strain no
Comments
Genome sequenced strain
Medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic, 3-5% O2-10% CO2
Name of Depositor P Guerry-Kopecko
Chain of Custody ATCC <-- P Guerry-Kopecko
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
References

Russell RG, et al. Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect. Immun. 57(5): 1438-1444, 1989. PubMed: 2707853

Cross References

Nucleotide (GenBank) : CP000538 Campylobacter jejuni subsp. jejuni 81-176, complete genome

Nucleotide (GenBank) : CP000549 Campylobacter jejuni subsp. jejuni 81-176 plasmid pTet, partial sequence

Nucleotide (GenBank) : CP000550 Campylobacter jejuni subsp. jejuni 81-176 plasmid pVir, complete sequence